OCUMENSION THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.84 HKD | +1.48% |
|
+1.18% | +2.40% |
| 04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
| 04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 608M | - | |||||
| 796B | ||||||
| 628B | ||||||
| 358B | - | - | - | - | ||
| 331B | ||||||
| 301B |
